# US 2021/0147904 A1 · Methods for delivering an analyte to transmembrane pores

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0147904 A1
- Document ID: US20210147904A1
- Status: Published application
- Kind: A1
- Application number: 16/902,306
- Filed: 2020-06-16
- Published: 2021-05-20
- Earliest claimed: 2014-10-17
- Assignees: Oxford Nanopore Technologies PLC
- Applicants: Oxford Nanopore Technologies Ltd.
- Inventors: Clive Gavin Brown; Daniel Ryan Garalde; Andrew John Heron; Daniel John Turner; James White
- Web page: https://patentgrep.com/patent/US20210147904A1

## CPC

- C12Q 1/6804: Nucleic acid analysis using immunogens (immunoassay G01N33/53)
- C12N 9/52: derived from bacteria {or Archaea}
- C12N 15/1013: {by using magnetic beads}
- C12Q 1/6869: Methods for sequencing
- G01N 33/48721: {Investigating individual macromolecules, e.g. by translocation through nanopores (Coulter counters in general G01N15/12; fabrication methods for nanoscale apertures B81B1/00; sequencing of nucleic acids C12Q1/68)}
- G01N 33/48728: {Investigating individual cells, e.g. by patch clamp, voltage clamp (investigating individual particles in general G01N15/10)}
- G01N 33/6872: {Intracellular protein regulatory factors and their receptors, e.g. including ion channels}
- B03C 2201/18: Magnetic separation whereby the particles are suspended in a liquid
- C12Q 2523/303: Applying a physical force on a nucleic acid
- C12Q 2525/197: incorporating a spacer/coupling moiety
- C12Q 2563/149: Particles, e.g. beads
- C12Q 2563/155: Particles of a defined size, e.g. nanoparticles
- C12Q 2565/631: being a biochannel or pore
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B03C: MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS (separating isotopes B01D59/00; combinations of magnetic or electrostatic separation with separation of solids by other means B03B, B07B)

## Abstract

The invention relates to a new method of delivering an analyte to a transmembrane pore in a membrane. The method involves the use of microparticles.

## Claims

### Claim at position 1

-40. (canceled)

### Claim 41

A method for delivering a polynucleotide to a transmembrane pore in a membrane and characterising the polynucleotide, the method comprising:
(a) providing the polynucleotide attached to a microparticle;
(b) delivering the microparticle towards the membrane and thereby delivering the polynucleotide to the transmembrane pore, wherein the method comprises the microparticle moving (i) along the membrane; and/or (ii) in parallel with the membrane;
(c) allowing the polynucleotide to interact with the transmembrane pore such that the polynucleotide moves through the pore, and using a polynucleotide binding protein to control the movement of the polynucleotide through the pore; and
(d) taking one or more measurements as the polynucleotide moves with respect to the pore, wherein the measurements are indicative of one or more characteristics of the polynucleotide, and thereby characterising the polynucleotide;
wherein the polynucleotide detaches from the microparticle when interacting with the pore.

### Claim 42 (depends on 41)

A method according to claim 41, wherein the method is for delivering an increased concentration of a polynucleotide to a transmembrane pore in a membrane, wherein the concentration of the polynucleotide delivered to the transmembrane pore is preferably increased by at least about 10 fold.

### Claim 43 (depends on 41)

A method according to claim 41, wherein the method comprises (a) allowing the microparticle to move along an electrochemical gradient, diffusion gradient, hydrophilic gradient or hydrophobic gradient (b) allowing the microparticle to move within a magnetic field; (c) allowing the microparticle to move within an electrical field; (d) allowing the microparticle to move under pressure; or (e) allowing the microparticle to move with gravity.

### Claim 44 (depends on 41)

A method according to claim 41, wherein 2 or more, 3 or more, 4 or more, 5 or more, 6 or more, 7 or more, 8 or more, 9 or more, 10 or more, 20 or more, 30 or more, 50 or more, 100 or more, 500 or more, 1,000 or more, 5,000 or more, 10,000 or more, 100,000 or more, 1000,000 or more or 5000,000 or more polynucleotides are attached to the microparticle.

### Claim 45 (depends on 41)

A method according to claim 41, wherein the polynucleotide comprises one or more anchors which are capable of coupling to the membrane, optionally wherein the anchors comprise a polypeptide anchor and/or a hydrophobic anchor.

### Claim 46 (depends on 41)

A method according to claim 41, wherein the polynucleotide is attached to the microparticle via hybridisation and/or wherein the polynucleotide comprises one or more anchors which are capable of coupling to the membrane and the one or more anchors are linked to the polynucleotide via hybridisation.

### Claim 47 (depends on 41)

A method according to claim 41, wherein the microparticle is 500 m in diameter or less and is formed from a ceramic, glass, silica, a polymer or a metal or is magnetic.

### Claim 48 (depends on 41)

A method according to claim 41, wherein the transmembrane pore is a transmembrane protein pore, optionally wherein the transmembrane protein pore is derived from Mycobacterium smegmatis porin (Msp), α-hemolysin (a-HL) or lysenin.

### Claim 49 (depends on 41)

A method according to claim 41, wherein the method further comprises removing the microparticle from the membrane, optionally using a magnetic field or flow-based method.

### Claim 50 (depends on 41)

A method according to claim 41, wherein the method comprises:
(a) providing a first polynucleotide in a first sample attached to a first microparticle;
(b) delivering the first microparticle towards the membrane and thereby delivering the first polynucleotide to the transmembrane pore;
(c) removing the first microparticle from the membrane and optionally removing the first polynucleotide;
(d) providing a second polynucleotide e in a second sample attached to a second microparticle;
(e) delivering the second microparticle towards the membrane and thereby delivering the second polynucleotide to the transmembrane pore.

### Claim 51 (depends on 50)

A method according to claim 50, wherein:
(A) the method further comprises (i) between steps (b) and (c) allowing the first polynucleotide to interact with the transmembrane pore and taking one or more measurements during the interaction, wherein the measurements are indicative of the presence, absence or one or more characteristics of the first polynucleotide and/or (ii) after step (e) allowing the second polynucleotide to interact with the transmembrane pore and taking one or more measurements during the interaction, wherein the measurements are indicative of the presence, absence or one or more characteristics of the second polynucleotide; or
(B) the first and second analytes are polynucleotides and the method further comprises (i) between steps (b) and (c) allowing the first polynucleotide to interact with the transmembrane pore such that the first polynucleotide moves through the pore and taking one or more measurements as the first polynucleotide moves with respect to the pore, wherein the measurements are indicative of one or more characteristics of the first polynucleotide, and thereby characterising the first polynucleotide and/or (ii) after step (e) allowing the second polynucleotide to interact with the transmembrane pore such that the second polynucleotide moves through the pore and taking one or more measurements as the second polynucleotide moves with respect to the pore, wherein the measurements are indicative of one or more characteristics of the second polynucleotide, and thereby characterising the second polynucleotide.
